These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7225281)

  • 1. Immunological and biochemical characteristics of acid citrate eluates from tumour cells: a major non-immunoglobulin component.
    James K; Davis S; Merriman J
    Br J Cancer; 1981 Mar; 43(3):294-304. PubMed ID: 7225281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of host immunoglobulins with solid tumours in vivo.
    James K; Bessos YH; Merriman J
    Br J Cancer; 1979 Nov; 40(5):689-700. PubMed ID: 315785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to tumour eluates react preferentially with non-lymphoid tumours.
    Boyd JE; James K
    Cancer Immunol Immunother; 1983; 15(1):54-8. PubMed ID: 6553508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
    Dean CJ; Hobbs SM; Hopkins JU; North SM; Styles JM
    Br J Cancer; 1982 Aug; 46(2):190-7. PubMed ID: 7150472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses, antitumour antibodies and Ig class and subclass levels in C. parvum treated mice.
    James K
    Dev Biol Stand; 1977 Apr 13-15; 38():173-81. PubMed ID: 608503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxic autoantibodies eluted from in vivo propagating sarcoma cells of mice.
    Ran M; Yaakubowicz M; Witz IP
    J Natl Cancer Inst; 1978 Jun; 60(6):1509-13. PubMed ID: 206714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
    James K; Willmott N; Milne I; McBride WH
    J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay.
    Gupta RK; Leitch AM; Morton DL
    Clin Exp Immunol; 1983 Sep; 53(3):589-99. PubMed ID: 6193912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E.
    Cianciolo GJ; Lostrom ME; Tam M; Snyderman R
    J Exp Med; 1983 Sep; 158(3):885-900. PubMed ID: 6193238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring antibodies against fibrosarcoma and glioma cells in rats.
    Itaya T; Moriuchi T; Kodama T; Sendo F; Kobayashi H
    Gan; 1982 Jun; 73(3):454-61. PubMed ID: 7129010
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.
    Szymaniec S; James K
    Br J Cancer; 1976 Jan; 33(1):36-50. PubMed ID: 1252329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat tumour allografts evoke anaphylactic antibody responses.
    Broom BC; Alexander P
    Immunology; 1975 Jun; 28(6):1033-40. PubMed ID: 48504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 17. Elution of cytomegalovirus antibodies from adenocarcinoma of the colon.
    Grail A; Norval M
    Gut; 1985 Oct; 26(10):1053-8. PubMed ID: 2996990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between immunoglobulin and macrophages in primary methylcholanthrene-induced sarcomas.
    Wood GW; Tilzer SA; Gollahon KA; Lindsay JM
    Cancer Res; 1979 Nov; 39(11):4588-93. PubMed ID: 498089
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of specific cell-dependent antibody during growth of a syngeneic rat sarcoma.
    Basham C; Currie GA
    Br J Cancer; 1974 Mar; 29(3):189-98. PubMed ID: 4830142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Origin of immunoglobulins bound to the surface membranes of malignant cells in non-lymphoid forms of acute human leukemia].
    Ol'shanskiĭ AIa; Miterov GIu; Bulycheva TI
    Biull Eksp Biol Med; 1981 Apr; 91(4):473-6. PubMed ID: 6942896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.